A model based on radiomic features extracted from CT scans can help predict which ground glass nodule (GGN) cases require surgery and may reduce overtreatment, according to researchers at the Affiliated Suzhou Hospital of Nanjing Medical University in Suzhou, China.

Powered by Philips HealthSuite, open platform offers radiologists comprehensive data analytics in medical imaging

A machine learning algorithm based on perfusion-weighted MRI accurately differentiated between benign and malignant tumors in the uterus, according to researchers at Tehran University of Medical Sciences (TUMS) in Iran.

The American Cancer Society (ACS) released a new report highlighting the current state of cancer screening and put forth specific areas requiring further attention to fully maximize the potential of screening to combat cancer.

Brightness of the shoulder’s deltoid muscle on ultrasound can identify patients with type 2 diabetes or pre-diabetes with almost 90 percent accuracy, according to a study being presented at the Radiological Society of North America (RSNA)’s 2018 Annual Meeting next week in Chicago.

“The new 2018 Digital Mammography QC Manual will promote uniformity and consistency of QC procedures across the broad spectrum of FDA approved manufacturers,” Eric Berns, PhD, manual author and chair of the ACR Subcommittee on Mammography Quality Assurance, said in a prepared statement.

A New York City-based medtech startup called Ezra is about to replace pain inducing blood tests and biopsies with MRIs as part of its new prostate cancer screening subscription service, according to a recent report by TechCrunch.

A new special edition of the International Journal of Radiation Oncology•Biology•Physics will focus on imaging in radiation oncology, with more than 70 studies and essays available for free on the topic from Nov. 26-30.

“This technology can also be valuable to monitor high-risk patients who have increased risk of ovarian and breast cancers due to their genetic mutations,” Quing Zhu, PhD, and lead author of a recent Radiology study said.

The use of [18F]Fluciclovine-PET imaging is steadily increasing in patients with suspected prostate cancer, but a new single-center study published in the Journal of the American College of Radiology found some have more difficulty undergoing the exam than others.